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Introduction: The EU legislation on Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)
aims to improve the level of human health and environmental protection which has also implications for
occupational health and safety. The authors describe their own subjective definition of ‘the ideal REACH world’
from an occupational point of view as a desirable but unobtainable goal. The practicability of proposed REACH
instruments is discussed in relation to specific constraints imposed by the legal framework itself and by
contravention against and misinterpretation of the law. This is based on their experiences from within a competent
authority.
Results: The first years of REACH were characterised by learning-by-doing for all those involved in developing and
implementing this legislation. All of the elements of the REACH process have been started and for occupational
safety experts, the question arises whether these procedures improve the health and safety at the workplace.
Although REACH delivers new benchmarks (e.g. derived no-effect levels (DNELs)) to substantiate risk assessment at
the workplace many instruments still need improvement. The warranty of validity, usability and accessibility of the
collected data as well as the thorough description of safe uses (in eSDS) in the whole supply chain will be great
challenges in the next years. Additionally, although the candidate list is one of the most promising tools by driving
the process of substitution, the prioritisation is not efficient to improve occupational health and safety.
Discussion: The legislation cannot deliver on all of the expectations met in ‘the ideal REACH world’ from an
occupational point of view since it is necessary to also consider issues such as the principle of proportionality, the
complexity of the legislation, competing objectives, and scientific limitations. It is early days for the REACH process;
consequently, work practices, guidelines and legal decisions need to be further improved to achieve the required
compliance. These changes will help to reduce problems associated with implementation and clarify interpretation
of the legal text. Overall, the required outcomes from the REACH process can be achieved for the workplace with
the will and support of those involved in implementing the relevant health and safety legislation.
Keywords: REACH; Occupational health and safety; Derived no-effect level; Chemical safety report; Exposure
scenario; Safety data sheet; Worker legislation; Worker; Registration; SVHC; Candidate listBackground
On 1 June 2007, the legislation on the Registration,
Evaluation, Authorisation and Restriction of Chemicals
(REACH) came into force. REACH shall ensure the safe
manufacturing, placing on the market and use of chemi-
cals in the European Union. Registration aims to deliver
data on hazards as well as descriptions of appropriate
risk management measures (RMM). Evaluation com-
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reproduction in any medium, provided the origquality of the registrations, and to remove data gaps and
identify risks which need further regulation. Where risks
are not being properly controlled, REACH provides two
risk management measures: authorisation and restric-
tion. To date (status May 2013), approximately 28,000
registration dossiers for substances were submitted and
processed. The dossier evaluation is ongoing and 427
dossiers have been checked for compliance by the end of
2012 [1]. The substance evaluation has only started in
2012 and the first draft decisions on information re-
quirements have been submitted to the registrants. Sub-
sequent conclusions on the necessity of further risk
management measures are still pending for most sub-
stances. The inclusion of substances in the candidate listringer. This is an open access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
Table 1 Registration duties for different tonnage bands
and corresponding deadlines within the framework of
REACH




≥1,000 t/a 3.5 years Dec. 1, 2010
CMR substances ≥1 t/a 3.5 years Dec. 1, 2010
Environmental hazards ≥100 t/a 3.5 years Dec. 1, 2010
≥100 t/a 6 years Jun. 1, 2013
≥1 t/a 11 years Jun. 1, 2018
t/a, tonnes per annum.
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high concern (SVHC) has made good progress. Twenty-
two substances are included into Annex XIV, and for 11
substances (status December 2013), the latest application
date has already expired. The first restrictions proposed
by Member States have been adopted and Annex XVII
has been amended [2-4]. Deeper insight into the afore-
mentioned instruments of REACH and their legal back-
ground can be found elsewhere [5] and will therefore
not be discussed herein.
REACH objectives with regard to occupational health
and safety
The prerequisite to apprehend the authors' approach in
reflecting REACH is to understand their definition of an
ideal workplace achieved by the instruments given with
REACH. In the discussion, the term ‘the ideal REACH
world’ is a benchmark with which the current and future
implementation and its influence on the health and
safety of workers are compared. As the use of the term
‘ideal’ indicates the authors are of the opinion that the
henceforth described ‘world’ can and will not exist:
‘The ideal REACH world’ required that all harmful
substances existing at the workplace would be fully reg-
istered. Each of these substances would have a corre-
sponding technical dossier complemented by a chemical
safety report (CSR) in which adequate and conclusive
exposure scenarios (ES) describing the safe use of sub-
stances in their whole life cycle would be included. This
would be underpinned by a full, valid and unambiguous
physicochemical and toxicological assessment of the
hazardous properties of a substance including limit
values for these harmful effects. Relevant SVHCs would
be replaced by less hazardous, alternative substances or
processes. All information would be communicated
clearly and concisely, meeting the needs and knowledge
of all user groups along the whole supply chain. The rec-
ommended measures would be applied by the down-
stream users. If these ideals were met and all of those
managing processes complied accordingly, chemical haz-
ards would be adequately controlled in the workplace.
In the following, the authors want to reflect whether
‘the ideal REACH world’ can be met and whether
REACH will lead to improvements in occupational
health and safety.
Introduction
The REACH regulation aims to ensure a high level of
protection for the environment and human health as
well as improving the function of the European trading
and manufacturing markets [6]. The burden of proof
that has been transferred to industry is to ensure that
manufacturing, importing, distribution and use of sub-
stances does not cause adverse effects. This requirementapplies to manufacturers, importers, distributors and
downstream users within the supply chain. However,
there is an overlap between the objectives of this legisla-
tion and those which already apply to protect workers
from the risks of exposure to hazardous substances.
REACH legislation applies without prejudice to work-
place health and safety legislation (e.g. 98/24/EC, 2004/
37/EC [7,8]).
The European Commission states that ‘the arrival of
REACH does not mean that employers' obligations are
duplicated’. Employers have little more to do than review
their risk management in the light of new information
received and implement changes where necessary [9].
Thereby, REACH supports duties of employers under
workplace legislation by improving for example the em-
ployers' risk assessment with additional information.
Simultaneously, registrants' compliance with REACH in
terms of appropriate and correct chemical safety assess-
ment depends on input from knowledge about the proper-
ties of substances during their specific uses at workplaces.
This information is already required by health and safety
legislation and is part of the mandatory risk assessment
for activities involving hazardous substances or processes.
One of the main aims for REACH implementation is
to fill data gaps about possible hazards of chemicals
manufactured, imported and used at community level.
Information is compiled by the registrants and conveyed
to the European Chemicals Agency (ECHA) where this
information is collated. The obligation to register sub-
stances on their own or in mixtures manufactured and
imported in the EU in quantities of one tonne or more
per year will be completed on the first of June 2018 (for
reference see Table 1). Then ECHA will have gathered
the most extensive structured data collection on chemi-
cals compared to anywhere else worldwide.
Results
In the following chapter, the authors describe the potential
of the REACH instruments to improve occupational
health and safety from their point of view by comparing it
to the outlined REACH ‘ideals’. The impact of the
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new exposure limits, the extended safety data sheets, and
the substitution of SVHC on workers' health and safety
are discussed in separate paragraphs.
General obligation to register and information
requirements
In ‘the ideal REACH world’, all substances alone, or in
mixtures, would be registered with a complete submis-
sion of valid and conclusive data (for reference see first
column of Additional file 1).
However, the registration processes under REACH do
not require that each chemical substance in the work-
place is covered and fully examined. The regulation gen-
erally exempts certain substances (e.g. non-isolated
intermediates or waste) and sectors extensively regulated
by other legislation (e.g. use as a biocide). Annexes IV
and V of REACH list other substances excluded from
registration either because this is deemed inappropriate
or because sufficient information is available already.
A minimum tonnage of the manufactured or imported
substance is necessary to trigger registration (1 t/a). The
extent of mandatory information is reduced for on-site
isolated (OSII) and transported isolated intermediates
(TII). The toxicological information requirements increase
with increasing tonnage bands only. From an occupational
point of view, the profile of use of a substance and infor-
mation about high exposures and wide dispersive pro-
fessional uses would serve as more effective triggers.
Read-across approaches and waiving of studies can also
be justified. The registration requirements of REACH
exclude chemical agents not intentionally produced or
those present in the workplace for reasons not directly
associated with occupation [7].
In addition to the exemptions described above, the
complexity of the regulation may make compliance a
challenge. Some interpretations of the legal text are still
subject to interpretation by the member states, ECHA,
the Commission and the relevant bodies (RAC, SEAC)
established under REACH. A summary of the more
prominent drawbacks in the legislation relevant to the
registration requirements is given in the second column
of Additional file 1.
Based on the recent experience, reasons for non-
compliance can be various. One example of non-
compliance with legal provisions is that the exemptions
from the registration requirements are not correctly
understood. A very common problem is that the identity
of the substance under consideration is often not clear
or even incorrect [10]. Furthermore, the definition of in-
termediates and the term ‘strictly controlled conditions’
(SCC) is interpreted differently between the authorities
and some companies [11]. To avoid unjustified toxico-
logical tests, read-across approaches are made or certaintoxicological tests are waived for unjustified reasons.
Furthermore, the compilation of registration dossiers is
performed very differently by each SIEF and different
registrants may comply differently in a way not readily
understandable for competent authorities or the down-
stream users. Non-compliance with the legal framework
will occur when these assumptions, and estimations are
not disclosed and/or not justified and when the technical
dossier and the CSR are inconsistent. A non-exhaustive
summary of these discrepancies is summarised in col-
umn 3 of Additional file 1.
Overall, the data requirements of REACH represent a
meaningful step towards collecting structured informa-
tion on all substances present in the European market. It
will be the great challenge in the future to ensure the
validity, usability and accessibility of these data.
Chemical safety report
In ‘the ideal REACH world’, the CSR for all hazardous
substances would include adequate and conclusive ex-
posure scenarios describing safe uses of the substance
sufficient for workplace risk assessments (see column 1
of Additional file 2).
A CSR is obligatory for all registered substances used
above 10 tonnes per annum and if the substance fulfils
the criteria for hazards listed in Regulation (EC) No
1272/2008 (or PBT or vPvB), then exposure scenarios
also need to be developed. These exposure scenarios de-
scribe the processes, operational conditions and RMM
for the safe use throughout the whole life cycle for a
substance. This is the centrepiece of REACH by which
standards of health and safety at work can be raised, but
the requirements of the CSR are challenging.
The registrant is obliged to describe the manufacture
and use of the substance for all workplaces along the
supply chain, even for processes the manufacturer does
not control. Frequently, the supply chain is long and
complex and a direct exchange with those end users
who understand relevant workplace circumstances af-
fecting exposure level is not possible. Various combina-
tions of operational conditions and RMM can be chosen
to achieve a safe use. The challenge is to choose and im-
plement realistic parameters in accordance with work-
place legislation. This demands sufficient input and
experience from the downstream users to create a high
level of abstraction; this was not required from manufac-
turers and importers before REACH.
Therefore, registrants commonly describe exposure
scenarios on the basis of newly developed models which
are based on more generic-tiered and conservative ap-
proaches. Mechanisms for upstream communication
about new or deviating information on hazards and clas-
sification, impracticable parameters and the appropriate-
ness of certain RMM are required under REACH, but
Table 2 Types of relevant DNELs for workers
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factors that limit the attainment of ‘the ideal REACH
world’ at the workplace is summarised in column 2 of
Additional file 2.
A list of factors that lead to non-compliance within
the legal framework is given in column 3 of Additional
file 2. One reason for non-compliance with the legal
framework is that the whole life cycle of use for a sub-
stance is not covered. Maintenance work, cleaning of the
facilities, and waste/recycling of the substance are uses
frequently neglected from consideration. The evaluation
processes show that in some cases, exposure scenarios
are missing for common uses or that invalid exposure
scenarios are provided. Hazardous transformation and/
or degradation products from which a risk arises are not
assessed in the scenarios describing the use of their pre-
cursor substances. The reasons for these deviations are
usually based on missing or inefficient consultation or
missing or unsuitable feedback from downstream users
during the boundary conditions that applied for the first
registration deadline in 2010. Further non-compliance
can be attributed to registrants' failure to realise that the
REACH regulation applies without prejudice to the work-
place health and safety legislation. For example, the
hierarchy of measures defined under STOP principle
(substitution, technical measures, organisational mea-
sures, and personal protective equipment) has to be im-
plemented [7]. Whilst an assessment of substitutes is
not required of the REACH registrant, they are ex-
pected to follow the TOP principle whereby the use of
personal protective equipment to reduce exposure to a
hazard is further down the control hierarchy and other
measures of control have to be considered first. The
permanent use of personal protective equipment is not an
adequate means to minimise the risk of exposure in the
long term, and is not considered acceptable in most cases;
especially in cases technical measures could be applied
instead.
Another aspect of this process is that registrants need
to assess substances alone and not in the context of
other substances in a mixture. An assessment for a sub-
stance in all existing mixture combinations would be im-
possible for the registrants. Whilst other potentially
hazardous substances cannot be considered in undertak-
ing the REACH registration of a specific substance these
do need to be included when duty holders conduct a risk
assessment of the workplace under existing health and
safety legislation. In the context of workplace legislation,
the definition of hazardous substances is wider than the
scope of REACH and comprises substances classified ac-
cording to the Classification, Labelling and Packaging
(CLP) legislation and those that do not meet the CLP
classification criteria but may be a hazard under work-
place circumstances [7].REACH requires manufacturers and importers to de-
scribe safe uses of their substances in the supply chain
for the first time. This task is challenging. Whether the
REACH process can deliver its benefits for occupational
health and safety mainly depends on the efforts of industry
and the value of the feedback from downstream users.
DNELs - new exposure limits?
In ‘the ideal REACH world’, limit values would apply to
all hazardous substances to inform control actions (for
reference, see column 1 of Additional file 3).
At the EU level, two concepts for deriving occupa-
tional exposure limit values exist. The first being binding
occupational exposure limit values (BOELVs) for which
member states are obliged to derive national limit values
equal to or lower than the BOELV [7,8,12]. For their
derivation, toxicological information, socio-economic in-
formation and technical feasibility factors need to be
taken into account [13]. The second set are the indica-
tive occupational exposure limit values (IOELVs) [14-16]
for which member states are obliged to derive national
limit values that can either be higher or lower than these
IOELVs. These limit values were based on consideration
of evidence for an impact of the substance on health
[13]; currently 5 BOELVs and 112 IOELVs have been set.
For both sets of limits, the focus is on airborne exposure
rather than dermal contact. The progress with the EU
standards can be compared to historical national expos-
ure limits. For example, in Germany, occupational ex-
posure limit values for inhalation have been derived for
386 substances [17].
Annex I of the REACH regulation introduces new
health-based reference values above which humans
should not be exposed. This level of exposure is the de-
rived no-effect level (DNEL). As there are different types
of exposure and target groups (worker, consumer), dif-
ferent types of DNELs are defined. For the workplace,
eight types of DNELs are relevant (see Table 2).
As a rule for risk management, the lowest inhalation
DNEL and the lowest dermal DNEL are considered the
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tative dose–response relationships for the adverse effects
under discussion exist. For most carcinogenic and muta-
genic effects mechanistic considerations reveal a lack of
a threshold, and therefore, the derived minimal-effect
level (DMEL) shall be derived. However, this parameter
is not defined in the legal text, but only in the guidance
documents [13]. In Germany, a newly developed risk-
based concept for carcinogens is currently under evalu-
ation [18]. Three risk bands and respective tiered risk
management measures were agreed on by employees' and
employers' representatives and authorities. But across the
EU community, actors subject to REACH are left to make
the decision which risk reference values to apply to carcin-
ogens and mutagens for which a threshold effect level
cannot be determined. Therefore, there is a strong need to
implement a politically agreed risk value for these sub-
stances of high concern.
In an attempt to gain an overview of existing DNELs
and DMELs and to assess their impact on occupational
health and safety, the data from ECHA's publicly access-
ible database [19] were analysed.
After the first registration deadline on December 2010,
approximately 5,000 individual substances were regis-
tered including intermediates (OSII, TII) and low ton-
nage substances (1 to 10 t/a) for which no DNELs and
DMELs were derived. The analysis revealed 1,728 sub-
stances with unambiguous identity for which 4,765
DNELs and DMELs for workers were derived. Number
and type of DNELs and DMELs depend on the identified
uses and exposure scenarios submitted with the registra-
tion of a substance. In ECHA's public database, the
DNELs and DMELs are presented deep within the struc-
ture. An easily accessible and searchable source which
specifically provides DNELs and DMELs for registered
substances was made available by the German social ac-
cidence insurance [20]. It is not possible to conclude
whether all DNELs and DMELs required by REACH
have been derived because the number of DNELs and
DMELs depend on the hazard, the existing exposure and
the approach chosen.
Furthermore, when comparing publicly available data
with the chemical safety report which is not publicly ac-
cessible, DNELs and DMELs can sometimes be found in
the latter document only. Irrespective of these issues,
the number of existing DNELs and DMELs is signifi-
cantly higher than the number of BOELVs and IOELVs
that had been introduced at community level before
REACH came into force and higher than the number of
national, e.g. German, OELs [17]. DNELs are not work-
place limits that are legally binding and have not been
through a rigorous process of setting. They can only act
as guidance to assess whether the protection measures
taken are adequate.The Guidance Document R.8 describes the derivation
of DNELs [13]. In principle, DNEL derivation and OEL
derivation (at least in Germany) follow the same guide-
lines in extrapolation from experimental results onto
the workplace exposures limits. Figure 1 shows that ap-
proximately 60% of all DNELs were derived for chronic
systemic exposure routes. Since chronic DNELs are in
principle lower than the corresponding acute DNELs, it
is rather uncritical to refer to chronic DNELs for acute
exposure, too. Hence, the derivation of chronic DNELs
will - in terms of management strategies for occupa-
tional health and safety - also be preventive to acute
effects.
The focus of DNELs seems to be primarily on systemic
effects. Hence, an underestimation of local effects (corro-
sion, irritation and sensitisation) cannot be excluded at
this point, and therefore, these effects seem to be insuffi-
ciently considered in the chemical safety assessments.
The analysis of DNELs also revealed that only for a
few substances, different registrants derived different
DNELs. Figure 2 shows that the difference between
registrant's DNELs ranges in the majority of cases be-
tween factors of 1 and 5, but in a few cases, the devia-
tions are more pronounced.
Table 3 displays the example of a single substance for
which three registrants derived three different values.
The DNEL of Registrants A and B diverge by a factor of
16.6 and registrants C submitted a DMEL instead of a
DNEL. The exemplary substance is not classified as a
carcinogen or mutagen and therefore there is no neces-
sity to derive a DMEL. Deriving a DMEL for such a sub-
stance is simply wrong. It also shows that confidence in
DNELs derived by registrants might be questioned.
However, the authors do not know whether a more sys-
tematic examination of the data would reveal a greater
prevalence of presumably incorrect DNELs and DMELs.
Although this discrepancy between DNELs in registra-
tions is obviously present, it does not negate the legal
framework but limits the anticipated REACH ‘ideal’ for
effective control of workplace exposures. Downstream
users of these registrants are confronted with different
reference values which might then lead to different
RMM being implemented. Stricter RMM might lead to
competitive disadvantages. Further reasons for non-
compliance in this area can be found in column 2 of
Additional file 3.
In the context of REACH, DNELs and DMELs are the
reference values that have to be compared with the
values derived for exposure. Uses of a substance that re-
sult in a risk characterisation ratio (RCR - quotient of
exposure level and effect level) below 1 are considered
to be safe, while RCR > 1 will require additional mea-
sures to be prescribed in the exposure scenario in order






































































































Figure 1 Distribution of DNELs and DMELs over different routes of exposure. A number of registered substances (1,728) showed clear
identity and had at least one DNEL or DMEL for workers. In sum, of 4,765 values, app. 60% were derived for chronic systemic exposure via skin
and inhalation. The DMELs are part of the displayed columns (orange) and contributed only to a small degree to all values.
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resulted in an increased number of benchmarks to define
harmful exposure levels. In addition, working practices
that are obviously unsafe (e.g., showing RCR much larger
than 1) may not be reported as an ‘identified use’ but as a
‘use advised against’. By this means some critical uses of
hazardous substances might decrease. Obviously, these
values are only helpful, if properly derived on the basis of
the most robust and latest data. The authors want to point
out that although DNELs and DMELs do not directly en-
tail legal consequences, with respect to workplaces, they
will be and are regarded as an additional reference value




























































Figure 2 Difference between DNELs of different registrations. The gra
the same substance. The factors were calculated relative to the lowest DNE
number of factors in the indicated range.Communicating information via (extended) safety
data sheets
In ‘the ideal REACH world’ the (extended) safety data
sheet would provide information that is clear and rele-
vant to workplace situations and would represent a
transfer from the registrant to the recipient and vice
versa (for reference see column 1 of Additional file 4).
The safety data sheet (SDS) shall enable the recipient
to take the necessary measures to protect the health of
workers and the environment. Under current health and
safety legislation the SDS is the main information source
for employers undertaking risk assessment involving















































ph shows the relative ranges of DNELs from different registrations for
Ls for each substance, and the bubble areas are proportional to the
Table 3 Example of a substance with three registrations
and the differing derived DNELs and DMEL
2,6-Di-tert-butyl-p-cresol Acute syst. inhal. Long-term syst.
dermal
Registrant A - DNEL 0.5 mg/m3
Registrant B - DNEL 8.3 mg/m3
Registrant C DMEL 2.0 mg/m3 -
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the relevant exposure scenario in an annex to the SDS.
This SDS is called extended safety data sheet (eSDS).
The (e)SDS links legislations of placing chemicals on the
market and worker protection. A CSR has to be pro-
vided for specific registered substances only; however, in
workplaces, mixtures of substances are commonly used
[22]. Therefore, most employers will be confronted with
exposure scenarios that apply only for a minority of their
workplace chemicals. It is the formulator as the first
downstream user who mainly has to deal with the prob-
lem of utilising the exposure scenarios provided in the
eSDS, and to consolidate them along with relevant infor-
mation into SDSs for their products. Exposure scenarios,
especially those for the workplace, are likely to be nu-
merous and specific to bespoke processes and business
practices. For a widely used solvent with for example 10
identified uses often as many as 80 different contributing
exposure scenarios are compiled. Many of these expos-
ure scenarios may be quite similar and differ only in
minor details. It is difficult to consolidate all of this in-
formation into a handful of relevant specifications for
safe handling as required in Sections 7 and 8 of the SDS.
This is an important issue as the SDS is intended to be a
clear and concise document, which takes into account
the specific needs and knowledge of the user group.
The new requirements concerning communication in
the supply chain and downstream user compliance are
sources of non-compliance with REACH (see a non-
exhaustive summary in column 3 of Additional file 4).
As a rule, the attached exposure scenarios are neither
available in a harmonised and structured format nor ag-
gregated into predictive descriptions that are representa-
tive for the majority of workplaces at the moment.
These problems clearly show the need to create a com-
mon format for the exposure scenarios and to clearly de-
fine and structure the relevant information that has to
be transferred from the CSR to the exposure scenario
annexed to the SDS. In addition, even though it is legally
acceptable to attach all exposure scenarios (see column
2 of Additional file 4), recipients would benefit more if
suppliers provided only those exposure scenarios rele-
vant to the recipient.
On the other hand, the recipient, be it the formulator
or the end user, has to check whether he complies withthe conditions set out in the exposure scenario received
with the substance. This is especially important in cases
downstream users receive a generic exposure scenario
and need to decide whether this is sufficient for a spe-
cific workplace. With respect to REACH, they are
obliged to apply, as a minimum, the conditions of the
exposure scenario communicated to them. With respect
to worker legislation, downstream users have to identify
further workplace-specific conditions and hazards in
their risk assessment. It is essential that inadequate ex-
posure scenarios are amended to enhance their value to
users of that information. In order to achieve this, recip-
ients need to give feedback to their supplier(s) on the
appropriateness of RMM, occupational conditions and
process parameters as well as the readability of the
eSDS. The quality of the CSR, especially the exposure
scenarios, will improve when the knowledge of end users
is fully integrated to ensure relevance of this informa-
tion. For example, do exposure scenarios point to prac-
tical and relevant control measures, or do they point to
measures that are potentially in conflict with other ele-
ments of health and safety legislation? REACH provides
two mechanisms to address the appropriateness of ex-
posure scenarios: the option to make details of a down-
stream use known to the registrant to enable him to
prepare appropriate exposure scenarios (articles 37(2) and
(3)) or the option of upstream communication of inappro-
priate RMM in received exposure scenarios (Article 34).
The first two REACH registration phases delivered
data that should have increased the quality of SDS [23].
At the moment, this envisaged improvement is hindered
by lack of experience, the use of instruments still under
development, especially for exposure assessment (Eteam
project [24]), lack of structured templates and lack of
easily exchangeable formats for information exchange
(under development: ESComXML) [25]. The rush to be
‘REACH-compliant’ to fulfil the minimum requirements
of registration of dossiers on schedule and to prepare (e)
SDS [23,26] might have led to the submission of incom-
plete and incorrect registration dossiers and the recom-
mendation of inappropriate RMM. The focus of industry
may shift to improving the quality of the registration
dossiers and SDS when these more time-consuming pro-
cesses are completed. Whilst the eSDS is still at an early
stage of implementation, the authors of this paper con-
clude that cooperation and improved awareness within
the supply chain can improve the foundation for the safe
handling of chemicals at workplaces.Substitution of substances of very high concern
In ‘the ideal REACH world’, all substances of which the
use comprises a risk would be identified and substituted
(see column one of Additional file 5).
Table 4 Inherent properties and their corresponding
scores
Inherent properties Score
C, M with threshold or R 0
C or M without threshold 1
PBT or vPvB 3
PBT and vPvB or PBT with T non-threshold Cor M 4
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the authors do not agree with the identification of SVHC
substances based only on their hazard classification
without risk characterisation of the substance as applied
at the moment. However, the legal text of REACH is not
so specific. SVHC by definition of the REACH regulation
are those substances that are included in the candidate
list for authorisation on the basis of their classification
as CMR, their PBT or vPvB properties or of their
equivalent level of concern (ELC) [27]. In 2010, the EU
commissionaires Tajani and Potočnik asked the Member
State Competent Authorities and ECHA to intensify
their work to accomplish the inclusion of 136 substances
into the candidate list. This goal was hardly achieved
and therefore the European Commission initiated a
roadmap of SVHC stating that until 2020, the candidate
list should contain all relevant substances [28].
The purpose of the candidate list can be interpreted
quite differently. The hazardous properties of a sub-
stance alone are sufficient for the SVHC identification,
and at first sight, filling the candidate list is straightfor-
ward. This approach can prevent the use of an equally
hazardous substance as an alternative. However, experi-
ence from workplace risk assessments demonstrates that
considering the hazard status alone without considering
the risk likelihood of exposure can be meaningless. Con-
sequently, when the risk is foreseeably low and can be
controlled by suitable RMM, the authors are of the opin-
ion that resources would be better allocated to activities
tackling substances associated with high risks.
The process of identifying SVHC is well under way
and constitutes a clear incentive for the continuous
elimination of CMR substances. However, CMR sub-
stances have always been in the focus of regulation [8]
and are a significant, but not the most frequent problem
in workplaces. Currently, the SVHC process is very fo-
cused on CMR substances and PBT/vPvB substances. So
far (status December 2013), only seven substances (re-
spiratory sensitisation, endocrine disruption) out of 144
were identified as SVHC due to article 57f where identi-
fication was of ‘equivalent level of concern’ to the re-
lated SVHC. From an occupational safety point of view,
it could be argued that substances with less pronounced
hazard properties, but high risks for exposure and harm
(e.g. substances that are skin sensitising or STOT RE)
might also be subjected to SVHC identification and au-
thorisation. In particular, substances causing dermal al-
lergies might be candidates for such considerations
because of the increasing frequency and gravity of skin
diseases as observed at a community level [29,30].
Nevertheless, this definitely needs a case by case investi-
gation and discussion of every single substance.
Substances listed in the candidate list may be priori-
tised by ECHA and the member state committee (MSC)for inclusion into Annex XIV of the REACH regulation.
The prioritisation approach developed by ECHA [31]
considers the inherent properties, the volume and the
wide-dispersive use of a substance. Each criterion is di-
vided into categories of different scores (initially pub-
lished values, see Tables 4, 5 and 6). These were
developed in a way that the criteria are weighed with
18%, 41% and 41%, respectively. The recommendation
criteria do not give priority to substances relevant for
worker exposure. The maximum score for inherent
properties can only be achieved in case of substances
that are PBT and vPvB or PBT with T being non-
threshold C or M. Giving the highest score to environ-
mental hazards was an attempt to promote the priori-
tisation of this specific concern since most of the
substances with PBT and/or vPvB properties have low
volumes and have proven to be hardly prioritised. Ac-
cording to the guidance given by ECHA [32], the ‘wide
disperse use of a substance is characterised by the as-
sumption that the substance is used by consumers or by
many users in the public domain, including small, non-
industrial companies’. Consequently, the high scoring
values for wide-dispersive use generally gives priority to
substances largely found in consumer products. From
our point of view, promotion of substances that are rele-
vant for worker exposure (e.g. widespread use: ‘Uses tak-
ing place at many places, which however do not result in
significant releases of a substance, may be considered
only as ‘widespread’ but not as ‘wide-dispersive’ [33]) is
missing. The following fictional example using revised
but not yet published scores shall elucidate that there
are scenarios that will clearly prevent a fast and neces-
sary promotion from the candidate list to Annex XIV of
a substance for which a risk has been identified: Assum-
ing to have a substance toxic to reproduction, that is
produced in volumes of 10 to 100 t/a and used
community-wide in a non-diffuse manner in 100 sites
would gain a score of 6. Assuming further that more
than 1,000 workers are exposed and limit values are
exceeded, further legislation is deemed appropriate from
occupational safety and health point of view. Since the
criteria do not take the risk into account, the substances
would not be prioritised for a long time due to a low
score. From our current experience, we would at least
question effectiveness as well as efficiency of the current





10 to 100 t/a 3
100 to 103 t/a 5
103 to 104 t/a 7
>104 t/a 9
Hammerschmidt and Marx Environmental Sciences Europe 2014, 26:6 Page 9 of 12
http://www.enveurope.com/content/26/1/6scoring system in relation to occupational health and
safety.
Eventually, the commission will decide on the inclu-
sion in Annex XIV which prohibits all uses of the sub-
stance unless authorisation for a specific use is granted.
An application date and the latest date of use (‘sunset
date’) will be announced and industry can decide
whether to apply for authorisation or switch to suitable
alternatives. Taking account of ECHA's capacities and
the undefined period of time for comitology to take
place, only a limited number of SVHC can be included
into Annex XIV at a time. The REACH legal text does
not specify if and when prioritisation from the candidate
list into Annex XIV will take place which causes great
planning uncertainties for industry. Authorisation shall be
granted if the risk to human health or the environment is
demonstrated to be adequately controlled (article 60(2)). If
adequate control cannot be demonstrated, authorisation
may only be granted if it is shown that socio-economic
benefits outweigh the risks (article 60(4)).
Substitution is always the preferred option, although it
is not always technically feasible - either by exchange of
the substance or by alternative technical processes, or by
a combination of these options. Considerations on suit-
able alternatives include an assessment whether the sub-
stitution will result in reduced overall risk and whether
the alternatives are technically and economically feasible
for the applicant. When there are no suitable alternatives,Table 6 Number of sites of substance and their
corresponding scores
Wide dispersive use Score
Number of Sites
0 0
0 to 10 1





Diffuse, significant, uncontrolled 3authorisation may be granted if the socio-economic bene-
fit outweighs the residual risks from using the substance.
The authors want to note that only the future will show
whether applicants with either few or many resources will
be treated equally upon authorisation applications. It will
be interesting to see if and how the committee for the
socio-economic assessment will tackle this topic.
In response to REACH implementation, industry
reacted proactively in some cases and even tried to
phase out substances that fulfil the criteria for inclusion
into the candidate list for Annex XIV (personal commu-
nication with industry). From this perspective, the au-
thors consider the impending authorisation process
based on the hazard status an effective instrument to
drive a focus on substitution. Whether such substitution
will result in the desired reduction of overall risks needs
to be examined. Sometimes, little is known about the
hazards and risks associated with alternative chemicals.
Even less is known about products imported into the
European Union that contain the same substances.
In conclusion, based on the authors' knowledge and
experience, the authorisation process is one of the most
promising tools under REACH by which improvement
of environmental and human safety and health can be
made driving the process of substitution. However, this
prioritisation is not in the authors' view being efficient
to improve occupational health and safety.
Discussion
In the authors' experience, the first years of REACH were
characterised by learning-by-doing for the industry, the
competent authorities, ECHA and non-governmental orga-
nisations. Since all of the relevant processes have started, a
first résumé can be drawn. In this paper, the authors have
assessed progress with implementing the REACH instru-
ments, highlighting promising developments, as well as
challenges and limitations particularly for occupational
health and safety:
Have the REACH instruments improved the health and
safety of workers in companies?
REACH aims to deliver structured and accessible infor-
mation on chemicals, e.g. toxicological and physico-
chemical information to achieve adequate classification
and labeling, or DNELs. Relevant data are publicly avail-
able in the ECHA database. Classification, information
on the uses, operational conditions and relevant risk
management measures are communicated via SDS. The
understanding of manufacturers and importers on the
life cycle of their substances has also increased. Bidirec-
tional communication and collection of knowledge
about hazardous substances in use have been achieved
in some cases ensuring more reliable data within the
supply chain. These achievements are clearly a large step
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safe use has been introduced and made available for
many substances that had no OEL before. Whilst the
quality of some of the DNELs/DMELs might need im-
provement, the derivation of these values is a gain for
occupational health and safety. The instrument of au-
thorisation for SVHC has also intensified industries' ef-
forts in substitution of the most hazardous chemicals.
From the authors' point of view, the transfer of the bur-
den of proof to the manufacturers and suppliers of che-
micals has increased their efforts to tackle unknown and
neglected risks from hazardous substances.
However, a gap in the application of these processes to
improve standards of occupational health and safety re-
mains. There are a number of caveats that have to be ap-
plied and which have been summarised in Additional
files 1, 2, 3, 4 and 5 (columns 2, respectively). These
current limitations should provide a focus to further de-
velop practical means for duty holders to apply REACH
in the context of occupational health and safety.
Anyway, ‘the ideal REACH world’ in which only ad-
equately controlled uses exist in relation to occupational
health and safety (reflected in Additional files 1, 2, 3 and
4 (columns 1, respectively)) can and will not exist. The
described picture is an unobtainable goal and serves as
an orientation for further efforts.
Which obstacles persist?
In article 1 of the REACH regulation, the goals are set
out to ensure a high level of protection of human health
and the environment based on the precautionary
principle, whilst improving free trade and circulation of
substances on the internal market enhancing both com-
petitiveness and innovation [27]. The combination of
these objectives in REACH is challenging: Global com-
petitiveness and adequately controlled risks can be con-
flicting interests. Obviously, the substitution of a SVHC
comprising high risks is desirable, but not always imme-
diately technically feasible. Furthermore, protection of
the environment, the consumer and the worker can be
competing objectives in relation to obligations stipulated
in the law and its interpretation. Meeting at least one of
these other obligations may present obstacles to improve
occupational health and safety standards. One example
is the definition of criteria for the prioritisation of SVHC
for inclusion in Annex XIV which may place substances
of high risk for the workplace on a holding position on
the candidate list.
These challenging objectives and the broad goals of
the REACH regulation are not the only sources of prob-
lems for implementing this legislation in the workplace.
The shifting of the burden of proof for the protection of
human health and the environment from the regulator
to the industry was challenging and time-consumingbecause industry had to adapt to these concepts and
introduce suitable processes. It is important that REACH
processes leave room for individual solutions as duty
holders and the companies they represent differ greatly
in their size, resource base and access to expert know-
ledge that will be required to address some aspects of
the legislation. But this simultaneously leads to draw-
backs. For example, the process for preparing exposure
scenarios is not prescribed in the legislation and so vari-
ous approaches have been developed. This is a challenge
for the recipients of the SDS coping with different
formats.
These principles and concepts will persist in the future
and will hinder the implementation of ‘the ideal REACH
world’ in relation to occupational health and safety. In
addition to the complexity of the legislation, scientific
limitations regarding occupational exposure to some
substance will also persist.
How can implementation problems be overcome?
Despite persisting problems, the authors are optimistic
that not all obstacles will remain. The interpretation of
the legal text will become more consistent. To increase
compliance with legal obligations and provide further
clarification support is offered at national and commu-
nity level in the form of guidance and immediate help-
desk support by authorities and industrial organisations.
This support is constantly adapted to the increasing
knowledge on the interpretation of the legal text and to
the common working practice. The industrial organisa-
tions seem to increase their efforts of support and
thereby gain more importance for duty holders. A good
overview on these industry sponsored activities can be
found on the Cefic website [34] or for a special focus on
exposure scenarios, in the exchange network on expos-
ure scenarios (ENES) [35].
Guidance is also being improved based on knowledge
from the workplace assessment of exposure and this is
being triggered by on-going evaluation processes per-
formed by ECHA and the member states. Evaluation is
one instrument that will reveal and reduce data gaps and
should reduce legal non-compliance of the type outlined
in Additional files 1, 2, 3 and 4 (columns 3, respectively).
When a registration dossier is submitted to ECHA, it
generally passes only an IT-supported accordance check
which might not reveal incorrect information. A closer
look at the registration dossiers is then carried out by
ECHA on 5% of the registrations via a formal dossier
evaluation. The focus so far has been on the evaluation
of toxicological assessment and environmental ques-
tions. ECHA's current approach shifts to a targeted ap-
proach, namely selecting specific points of concern.
Considering occupational health and safety, it is desir-
able to enhance the emphasis on exposure and risk
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exposure scenarios is difficult at the moment and in
most cases has to be done manually. Exposure scenarios
are submitted in the CSR in PDF format and are not part
of the registration dossier that is submitted in a struc-
tured and IT-searchable format (IUCLID) [36]. ECHA
provides an IT-application named CHESAR [37] that is
linked with IUCLID and able to generate the CSR and
exposure scenarios for communication in the eSDS in a
structured, harmonised and efficient way.
The first results of the evaluation processes show that
some exposure scenarios and risk management measures
from the first registrations may be very schematic, in-
complete, inadequate, and/or overprotective and may
not respect the hierarchy of risk management measures.
ECHA's current approach in dossier evaluation shifts to
a targeted approach, namely selecting specific points of
concern. Considering occupational health and safety, it
is desirable to enhance the emphasis on exposure and
risk management in the future.
Which REACH instruments need to deliver their
full potential?
While the registration, dossier evaluation and improve-
ment of communication along the supply chain are pro-
gressing, other REACH processes have just started.
The substance evaluation (SEv) process involves an in
depth analysis of a carefully selected set of substances (e.g.
missing information about substance properties reflecting
risks or exposure-related information) and highlight where
there is a need for further risk management or regulation.
These data gaps can be addressed by ECHA's decision on
additional requirements on the registrant. In those cases
where the SEv process identifies a need for further regula-
tion, authorisation requirements or restrictions might be
initiated. Only a few substances have been taken through
the SEv process to date, and so the value of this new in-
strument will only become clear in future. The first results
of the evaluation processes show that some exposure sce-
narios and RMM from the first registrations may be very
schematic, incomplete, inadequate, and/or overprotective
and may not respect the hierarchy of RMM. The SEv is a
promising instrument to identify work-related risks and to
decide if further regulation is needed.
The process of authorisation for SVHCs will achieve
its full potential in promoting substitution of hazards
when companies proactively change formulations and
downstream users demand that suppliers avoid using
SVHCs in their products. The process of identifying
SVHC and their prioritisation within Annex XIV leaves
room for improvement in assessing risks of exposure to
these substances in the occupational setting. Granted
authorisations cannot be evaluated so far as no decision
on an application has been made.Conclusions
In this article, the authors have evaluated the develop-
ment, challenges, and limitations to implementation of
REACH in the occupational setting in order to examine
to what extent the REACH ‘ideals’ can be achieved. In
some respects, this has proven challenging because of
the current ‘state of the art’ with REACH as well as
knowledge and experience of those implementing the le-
gislation. There is clearly ambiguity in the minds of
some regarding the application of REACH in their busi-
ness aspects, and concerns that the legislation is placing
a disproportionate burden on industry. The regulation is
still at an early stage of implementation after 6 years and
not all of the tools have fully been used or exploited to
their full potential. Quality control processes like dossier
evaluation, substance evaluation and regulatory pro-
cesses like SVHC identification, authorisation and re-
striction have just started. Some inherent legal aspects of
the process may hinder to reach the objectives in rela-
tion to health and safety at work, especially competing
objectives and those provisions that narrow the scope of
REACH. By the establishment of raised awareness, good
work practices, improved communication, further guide-
lines, and decisions of the national enforcement author-
ities as well as the European Court of Justice compliance
problems will be reduced. Therefore, the authors are
confident that with more routine experience of the
REACH processes and with support from all parties in-
volved, improvements in workplace health and safety
standards can be achieved although the outlined ‘ideal
REACH world’ cannot be achieved.
Additional files
Additional file 1: Data generated due to REACH registration duties
and reasons which oppose ‘the ideal REACH world’. Non-exhaustive
summary.
Additional file 2: Data generated through the CSR.
Additional file 3: Limit values generated through REACH.
Additional file 4: Communication of exposure scenario information
via (extended) safety data sheets.
Additional file 5: SVHC identification and substitution.
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